Crypto asset converter Bio Protocol to US Dollar
Easily convert Bio Protocol to US Dollar with our calculator. See the conversion trend and key exchange rates between BIO and USD.
Cryptocurrency Converter
Bio Protocol to USD — Market data
Market cap
$67.55M
24h Volume
$29.39M
Max supply
3.32B
Circulating supply
3.32B
Type
currency
Price of BIO/USD - Bio Protocol/Euro
The price of Bio Protocol is rising
The value of Bio Protocol is $0.0316. That means, to purchase 5 BIO, you will need to pay $0.1580. On the other hand, with $1.00, you can buy a total of 31.64346872 BIO, while $50.00 would allow you to make an acquisition of 1,582.17343578 BIO.
In the last 7 days, the price of Bio Protocol has increased by +12.07%. Meanwhile, in the last 24 hours, the price has changed by +4.90%.
Convert BIO to USD
| Amount | 06/12/2026, 03:42 AM |
|---|---|
| 0.5 BIO | $0.0158 |
| 1 BIO | $0.0316 |
| 2 BIO | $0.0632 |
| 5 BIO | $0.1580 |
| 10 BIO | $0.3160 |
| 50 BIO | $1.58 |
| 100 BIO | $3.16 |
| 500 BIO | $15.80 |
| 1000 BIO | $31.60 |
Convert USD to BIO
| Amount | 06/12/2026, 03:42 AM |
|---|---|
| $0.5000 | 0.01580105 BIO |
| $1.00 | 0.03160210 BIO |
| $2.00 | 0.06320420 BIO |
| $5.00 | 0.15801049 BIO |
| $10.00 | 0.31602098 BIO |
| $50.00 | 1.58010490 BIO |
| $100.00 | 3.16020980 BIO |
| $500.00 | 15.80104901 BIO |
| $1,000.00 | 31.60209802 BIO |
Buy Bio Protocol safely
Sign up with Bit2Me and access the most trusted cryptocurrency exchange platform to buy and sell Bio Protocol securely.
What is Bio Protocol?
Bio Protocol is a platform designed to accelerate scientific development through the decentralised funding and management of biotechnological projects. Its aim is to enable global communities of scientists, patients, and investors to collaborate on the creation and shared ownership of new drugs and therapies through decentralised autonomous organisations specialised in biotechnology, known as BioDAOs. The native token of Bio Protocol, called BIO, fulfils essential functions within the ecosystem. In addition to facilitating transactions, it grants its holders governance rights, allowing them to influence key decisions such as the selection of BioDAOs to support and the allocation of resources for the development of intellectual property assets. This approach seeks to democratise scientific research and encourage active community participation in biotechnological innovation.
